EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi

Frances S Faguy iD, Maciej Walczak, Bridget M Barker iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01225-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Frances S Faguy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Histidine Kinase, Protein Kinases, Coccidioides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thermal dimorphic fungal pathogens are fungi that infect humans, often through the inhalation of asexual conidia, and which transition from hyphae to yeast in the human body. These fungi cause severe or chronic mycoses and are typically treated with azoles or amphotericin B. Ambruticin, a polyketide antifungal, shows promise as an alternative therapy. It targets hybrid histidine kinases (HHKs), which are fungal-specific proteins essential for osmoregulation and parasitic morphology and are conserved across thermal dimorphic species. Targeting HHKs suggests that ambruticin may therapeutically treat infections from multiple fungi without causing mechanism-based toxicity. We explore ambruticin’s potential to effectively treat these fungal infections without major adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsHistidine KinaseProtein KinasesCoccidioidesFungiHumansFungal Proteins

Stichwörter der Autor:innen

Coccidioides immitisCoccidioides posadasiiCoccidioidomycosisambruticinfluconazolehybrid histidine kinase

Substanzen

Antifungal AgentsHistidine KinaseProtein KinasesFungal Proteins

Autor:innen und Institutionen

  • Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.
  • Department of Chemistry, University of Colorado, Boulder, Colorado, USA.

ORCID-Profile: Frances S Faguy, Bridget M Barker

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • NIH HHS

Zitieren

APA

Faguy, F. S., Walczak, M., & Barker, B. M. (2026). Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01225-25

Vancouver

Faguy FS, Walczak M, Barker BM. Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01225-25

BibTeX
@article{Faguy2026,
  author = {Faguy, Frances S and Walczak, Maciej and Barker, Bridget M},
  title = {Hybrid histidine kinases and antifungal warfare in thermal dimorphic fungi},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01225-25}
}
Kostenlos starten →